Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Curiel

Showing results (121-130 of 283) with videos related to

Pageof 29
Sort By:
Bone|December 27, 2006
Evolving gene therapy approaches for osteosarcoma using viral vectors: reviewM A Witlox, M L Lamfers, P I J M Wuisman, et al.
Obstetrics and Gynecology|January 1, 1997
Gene therapy and ovarian cancer: a reviewM N Barnes, J S Deshane, M Rosenfeld, et al.
Oncogene|July 22, 1998
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regressionS P Frizelle, J Grim, J Zhou, et al.
Breast Cancer Research and Treatment|June 1, 1997
Gene therapy strategies for carcinoma of the breastJ M Ruppert, M Wright, M Rosenfeld, et al.
Gene Therapy|November 1, 1996
E1A RNA transcripts amplify adenovirus-mediated tumor reductionL D Dion, K T Goldsmith, T V Strong, et al.
Gene Therapy|April 1, 1997
An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2M Wright, J Grim, J Deshane, et al.
Nature Biotechnology|May 20, 1999
A system for the propagation of adenoviral vectors with genetically modified receptor specificitiesJ T Douglas, C R Miller, M Kim, et al.
Gene Therapy|November 23, 2012
A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropismM O Alberti, J S Deshane, D D Chaplin, et al.
Human Reproduction (Oxford, England)|January 11, 2008
Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cellsM H Hassan, N Khatoon, D T Curiel, et al.
Cancer Gene Therapy|December 25, 2007
Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecanJ Uchino, K Takayama, A Harada, et al.
Pageof 29

Showing results (121-130 of 283) with videos related to

Sort By:
Pageof 29
Bone|December 27, 2006
Evolving gene therapy approaches for osteosarcoma using viral vectors: reviewM A Witlox, M L Lamfers, P I J M Wuisman, et al.
Obstetrics and Gynecology|January 1, 1997
Gene therapy and ovarian cancer: a reviewM N Barnes, J S Deshane, M Rosenfeld, et al.
Oncogene|July 22, 1998
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regressionS P Frizelle, J Grim, J Zhou, et al.
Breast Cancer Research and Treatment|June 1, 1997
Gene therapy strategies for carcinoma of the breastJ M Ruppert, M Wright, M Rosenfeld, et al.
Gene Therapy|November 1, 1996
E1A RNA transcripts amplify adenovirus-mediated tumor reductionL D Dion, K T Goldsmith, T V Strong, et al.
Gene Therapy|April 1, 1997
An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2M Wright, J Grim, J Deshane, et al.
Nature Biotechnology|May 20, 1999
A system for the propagation of adenoviral vectors with genetically modified receptor specificitiesJ T Douglas, C R Miller, M Kim, et al.
Gene Therapy|November 23, 2012
A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropismM O Alberti, J S Deshane, D D Chaplin, et al.
Human Reproduction (Oxford, England)|January 11, 2008
Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cellsM H Hassan, N Khatoon, D T Curiel, et al.
Cancer Gene Therapy|December 25, 2007
Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecanJ Uchino, K Takayama, A Harada, et al.
Pageof 29